T1	Disease 104 112	melanoma
T2	OrganismPart 401 406	PSMB8
T3	OrganismPart 411 416	PSMB9
T5	CellType 797 808	lymphocytes
T6	SupplementaryFile 34849 34870	Supplementary Table 1
T7	NumberOfSamples 35150 35153	155
T8	NumberOfSamples 35199 35202	156
T4	Age 35417 35420	age
T11	Sex 35422 35425	sex
T12	Disease 37143 37150	healthy
T13	Disease 37134 37139	tumor
T14	FactorValue 37134 37139	tumor
T15	FactorValue 37143 37150	healthy
T16	FactorValue 104 112	melanoma
T9	NumberOfSamples 36967 36970	472
T10	Disease 37415 37421	cancer
*	Equiv T10 T13
T17	CellLine 37571 37574	12T
T18	CellLine 37579 37583	108T
T19	CellLine 37824 37828	A375
T20	SupplementaryFile 38041 38068	Supplementary Tables 14, 15
T21	SupplementaryFile 38148 38170	Supplementary Table 16
T22	Compound 44265 44276	formic acid
T23	Chromatography 44303 44332	reversed-phase chromatography
T25	IonizationType 44626 44638	electrospray
T26	Instrument 44670 44685	Q-Exactive-Plus
T24	FractionationMethod 44531 44576	UltiMate 3000 RSLCnano-capillary UHPLC system
T27	AcquisitionMethod 44885 44899	data-dependent
T28	Modification 45638 45660	N-terminal acetylation
A1	Modification T28 variable
T29	Modification 45680 45700	methionine oxidation
T30	CleavageAgent 45782 45792	unspecific
